CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
We are very excited to launch our new website! Please take a few moments to click around and explore...